These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8277044

  • 1. Joint pains with psoriasis and long-term systemic etretinate therapy: a case report and summary of 12 cases.
    Ishida Y, Ozawa A, Ohkido M, Imai N.
    J Dermatol; 1993 Oct; 20(10):651-3. PubMed ID: 8277044
    [Abstract] [Full Text] [Related]

  • 2. The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study.
    Stern RS, Fitzgerald E, Ellis CN, Lowe N, Goldfarb MT, Baughman RD.
    J Am Acad Dermatol; 1995 Jul; 33(1):44-52. PubMed ID: 7601945
    [Abstract] [Full Text] [Related]

  • 3. Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results.
    Wolska H, Jabłonska S, Langner A, Fraczykowska M.
    Dermatologica; 1985 Jul; 171(5):297-304. PubMed ID: 3908171
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of etretinate on the liver in psoriasis.
    Camuto P, Shupack J, Orbuch P, Tobias H, Sidhu G, Feiner H.
    Am J Surg Pathol; 1987 Jan; 11(1):30-7. PubMed ID: 3789256
    [Abstract] [Full Text] [Related]

  • 5. Etretinate in pustular psoriasis of palms and soles.
    White SI, Marks JM, Shuster S.
    Br J Dermatol; 1985 Nov; 113(5):581-5. PubMed ID: 3904810
    [Abstract] [Full Text] [Related]

  • 6. Serial liver biopsies in psoriatic patients receiving long-term etretinate.
    Roenigk HH, Gibstine C, Glazer S, Sparberg M, Yokoo H.
    Br J Dermatol; 1985 Jan; 112(1):77-81. PubMed ID: 3970836
    [Abstract] [Full Text] [Related]

  • 7. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G, Schulze HJ, Färber L, Weidinger G, Steigleder GK.
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [Abstract] [Full Text] [Related]

  • 8. [Skeletal alterations associated with long-term etretinate therapy].
    Okada N, Higashiyama M, Morimoto S, Yoshikawa K.
    Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):547-52. PubMed ID: 1890751
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thrombocytopenia associated with etretinate therapy.
    Liang R.
    Acta Haematol; 1988 Apr; 79(2):112-3. PubMed ID: 3124469
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Etretinate therapy for psoriasis and other keratinizing disorders: a 10-year retrospective study in Singapore.
    Shahidullah M, Tham SN, Goh CL.
    Int J Dermatol; 1993 Sep; 32(9):686-9. PubMed ID: 7691773
    [Abstract] [Full Text] [Related]

  • 16. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C, Bevilacqua L, Apostolico V.
    Acta Derm Venereol Suppl (Stockh); 1994 Sep; 186():151-3. PubMed ID: 8073820
    [Abstract] [Full Text] [Related]

  • 17. Short-term etretinate for pustular psoriasis.
    Rubin MG, Hanno R.
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):896-7. PubMed ID: 4008697
    [No Abstract] [Full Text] [Related]

  • 18. PUVA, etretinate, and PUVA-etretinate therapy for pustulosis palmoplantaris. A placebo-controlled comparative trial.
    Rosén K, Mobacken H, Swanbeck G.
    Arch Dermatol; 1987 Jul; 123(7):885-9. PubMed ID: 3300565
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.